BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 5546024)

  • 21. [Control of subcutaneous calcium-heparin therapy by the thrombodensitogram].
    Porta A; Magni S; Camagna P; Donati M; Dinelli CA
    Minerva Med; 1985 Mar; 76(11):531-2. PubMed ID: 3982692
    [No Abstract]   [Full Text] [Related]  

  • 22. [The biologic control of long-term heparin therapy in the light of 115 cases of patients treated with subcutaneous calcium heparinate].
    Migne J; Monteil R
    Angeiologie; 1967; 19(5):27-31. PubMed ID: 5621969
    [No Abstract]   [Full Text] [Related]  

  • 23. [Criteria of treatment in the intravascular coagulation syndrome in children].
    Chipail A; Schneer JH
    Pediatria (Bucur); 1971; 20(5):457-62. PubMed ID: 5166666
    [No Abstract]   [Full Text] [Related]  

  • 24. [Low dosage of heparin. Theoretical and practical evaluation].
    Gormsen J; Feddersen C; Clausen NT
    Ugeskr Laeger; 1974 Apr; 136(16):865-70. PubMed ID: 4825561
    [No Abstract]   [Full Text] [Related]  

  • 25. [Remarks on the use of Ca heparinate by subcutaneous route in anticoagulant therapy].
    Vivien P
    Phlebologie; 1973; 26(1):15-21. PubMed ID: 4724445
    [No Abstract]   [Full Text] [Related]  

  • 26. [Resuscitation of patients with high risk of hemorrhage and thromboembolism. Biological supervision. Indications of controlled heparin therapy].
    Boneu B; Cathala B; Jorda MF; Bierme R; Lareng L
    Nouv Presse Med; 1972 Jan; 1(1):29-32. PubMed ID: 5061187
    [No Abstract]   [Full Text] [Related]  

  • 27. [Calciparin].
    Pineau MJ
    Soins; 1980 Nov; 25(21):21. PubMed ID: 6910160
    [No Abstract]   [Full Text] [Related]  

  • 28. Guidelines for administering heparin.
    Thurber CF
    J Maine Med Assoc; 1974 Sep; 65(9):212-3. PubMed ID: 4413614
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapeutics. Guidelines for heparin administration in thromboembolic disease.
    Prupas HM
    Postgrad Med; 1977 Aug; 62(2):157-61. PubMed ID: 882468
    [No Abstract]   [Full Text] [Related]  

  • 30. [Importance of heparin in infants with consumption coagulation disease caused by septicemia].
    de Aquino-Jaso ME; Olvera-Hidalgo C; Ramírez JI
    Bol Med Hosp Infant Mex; 1974; 31(1):73-84. PubMed ID: 4433389
    [No Abstract]   [Full Text] [Related]  

  • 31. [Thrombotic and thromboembolic complications and their prevention with heparin].
    Kucherskiĭ VM
    Urol Nefrol (Mosk); 1983; (2):69-74. PubMed ID: 6190288
    [No Abstract]   [Full Text] [Related]  

  • 32. [Heparin treatment of thromboembolic complications].
    Samama M; Kher A; Horellou MH; Conard J
    Agressologie; 1983 Nov; 24(10):495-500. PubMed ID: 6367509
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin.
    Monreal M; Lafoz E; Olive A; del Rio L; Vedia C
    Thromb Haemost; 1994 Jan; 71(1):7-11. PubMed ID: 8165649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin therapy by continuous intravenous infusion.
    Swanson M; Cacace L
    Am J Hosp Pharm; 1971 Oct; 28(10):792-5. PubMed ID: 5125174
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prevention of thromboembolism using subcutaneous heparin].
    Saggau W; Encke A; Schmidt U
    Chirurg; 1974 Sep; 45(9):407-9. PubMed ID: 4425325
    [No Abstract]   [Full Text] [Related]  

  • 36. Editorial: Hypercoagulability--1974.
    Stuart RK
    Can Med Assoc J; 1974 Apr; 110(8):881 passim. PubMed ID: 4824957
    [No Abstract]   [Full Text] [Related]  

  • 37. In vivo studies on the inhibition of coagulation by fractionated heparin and by a heparin analogue. I. Effects of heparin fractions.
    Schmitz-Huebner U; Balleisen L; Asbeck F; van de Loo J
    Thromb Haemost; 1981 Oct; 46(3):612-6. PubMed ID: 7031982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On pulmonary embolism--with a report on first experiences with subcutaneous heparin prophylaxis].
    Giehl HJ
    Dtsch Gesundheitsw; 1967 Sep; 22(39):1829-32. PubMed ID: 5600033
    [No Abstract]   [Full Text] [Related]  

  • 39. Systemic heparinization for femoral percutaneous coronary arteriography.
    Walker WJ; Mundall SL; Broderick HG; Prasad B; Kim J; Ravi JM
    N Engl J Med; 1973 Apr; 288(16):826-8. PubMed ID: 4693933
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pulmonary artery thromboembolism and the state of the blood coagulation system in severe cranio-cerebral trauma].
    Kuklina AS; Leĭbzon ND; Monakova EA; Naumenko VG; Shcherbakova EA
    Vopr Neirokhir; 1972; 36(4):25-8. PubMed ID: 5085148
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.